PMS2 and lymphoma: Homozygous MMR gene mutations (MLH1, MSH2, PMS2, MSH6 biallelic mutations) are associated with neonatal neurofibromatosis and are more prone to early severe malignancies, including hematological malignancies, lymphomas and gastrointestinal malignancies (26–28).